# Picard Medical to go public via merger with Altitude Acquisition Corp.

Picard Medical, parent of SynCardia Systems, entered a definitive business combination agreement with Altitude Acquisition Corp. to become a publicly traded company. The transaction estimates a pre-money enterprise value of $480 million for Picard Medical.

- Type: Acquisition
- Announced: 2023-04-24
- Where: United States
- Value: $480.0M
- Status: announced
- Products: total artificial heart
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Picard Medical](https://endata.com/companies/58017.md) (target)
- [SynCardia Systems](https://endata.com/companies/58018.md) (partner)
- [Altitude Acquisition Corp.](https://endata.com/companies/69889.md) (acquirer)

## Sources

- [altitudeac.com](https://www.altitudeac.com/press-releases/detail/48/picard-medical-and-its-subsidiary-syncardia-systems-a), 2023-04-24: "SynCardia manufactures, sells, and markets the world’s first and only FDA approved and commercially available Total Artificial Heart to replace the full functions of a failing or failed human heart."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.